{"title":"Mondher Toumi","description":null,"products":[{"product_id":"introduction-to-market-access-for-pharmaceuticals-9781138032187","title":"Introduction to Market Access for Pharmaceuticals","description":"\u003cp\u003eMarket access is the fourth hurdle in the drug development process and the primary driver for global income of any new drug. Without a strategy in place for pricing, showing value for effectiveness and an understanding of the target purchasers' needs, the drug will fail to reach its intended market value. \u003cb\u003e\u003ci\u003eIntroduction to Market Access for Pharmaceuticals\u003c\/i\u003e\u003c\/b\u003e is based on an accredited course in this area, taken from the European Market Access University Diploma (EMAUD), and is affiliated with Aix Marseille University.\u003c\/p\u003e \u003cp\u003eKey Features:\u003c\/p\u003e \u003cul\u003e \u003cli\u003eThe first guide to market access for pharmaceuticals based on tested teaching materials\u003c\/li\u003e \u003cli\u003eAddresses both pharmaceutical and vaccine products\u003c\/li\u003e \u003cli\u003eIncludes case studies and scenarios\u003c\/li\u003e \u003cli\u003eCovers market access consdierations for Western Europe, the USA, Japan and China\u003c\/li\u003e \u003cli\u003eExplains the impact the changing healthcare market will have on your product\u003c\/li\u003e \u003c\/ul\u003e","brand":"Mondher Toumi","offers":[{"title":"Default Title","offer_id":51420740157782,"sku":"9781138032187","price":157.62,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0886\/3206\/6390\/files\/9781138032187.jpg?v=1758922569"},{"product_id":"introduction-to-market-access-for-pharmaceuticals-taylor-francis-ltd-9781138457058-mondher-toumi","title":"Introduction to Market Access for Pharmaceuticals","description":"\u003cp\u003eSchools are often faced with dealing with children who have mild forms of obsessive compulsive disorder. Through increased understanding, staff can support children with minimum stress. This book answers questions including: What is obsessive compulsive disorder? What are the causes? How can school staff help the sufferer?\u003c\/p\u003e","brand":"Mondher Toumi","offers":[{"title":"Default Title","offer_id":52238215151958,"sku":"9781138457058","price":242.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0886\/3206\/6390\/files\/9781138457058.jpg?v=1767760088"},{"product_id":"managed-entry-agreements-and-funding-for-expensive-therapies-taylor-francis-ltd-9780367500269-mondher-toumi","title":"Managed Entry Agreements and Funding for Expensive Therapies","description":"\u003cp\u003eManaged Entry Agreements and Funding for Expensive Therapies examinesthe concept of MEA, detailing how depreciation of some specific therapies through intangible amortization is unavoidable.\u003c\/p\u003e","brand":"Mondher Toumi","offers":[{"title":"Default Title","offer_id":52269255000406,"sku":"9780367500269","price":70.32,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0886\/3206\/6390\/files\/9780367500269.jpg?v=1767802764"},{"product_id":"managed-entry-agreements-and-funding-for-expensive-therapies-taylor-francis-ltd-9780367500290-mondher-toumi","title":"Managed Entry Agreements and Funding for Expensive Therapies","description":"\u003cp\u003eManaged Entry Agreements and Funding for Expensive Therapies examinesthe concept of MEA, detailing how depreciation of some specific therapies through intangible amortization is unavoidable.\u003c\/p\u003e","brand":"Mondher Toumi","offers":[{"title":"Default Title","offer_id":52269255655766,"sku":"9780367500290","price":187.94,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0886\/3206\/6390\/files\/9780367500290.jpg?v=1767802769"}],"url":"https:\/\/www.bookshop.lt\/collections\/mondher-toumi.oembed","provider":"Bookshop","version":"1.0","type":"link"}